AI assistant
Sending…
LENZ Therapeutics, Inc. — Director's Dealing 2021
Jun 25, 2021
32045_dirs_2021-06-24_0d78497d-bc24-4c38-a7ed-c434c62053e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Graphite Bio, Inc. (GRPH)
CIK: 0001815776
Period of Report: 2021-06-24
Reporting Person: Bassan Abraham (Director)
More from LENZ Therapeutics, Inc.
Annual Report
2026
Apr 28
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Jan 21
Regulatory Filings
2026
Jan 7
Director's Dealing
2026
Jan 6